Betablokkere kan gavne patienter med KOL og hjertesygdom
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Betablokkere kan gavne patienter med KOL og hjertesygdom. / Rasmussen, Daniel Bech; Lange, Peter; Thorsten Jensen, Magnus.
In: Ugeskrift for Laeger, Vol. 178, No. 6, V02150184, 21.03.2016, p. 555-559.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Betablokkere kan gavne patienter med KOL og hjertesygdom
AU - Rasmussen, Daniel Bech
AU - Lange, Peter
AU - Thorsten Jensen, Magnus
PY - 2016/3/21
Y1 - 2016/3/21
N2 - Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatmentChronic obstructive pulmonary disease (COPD) and coronary heart disease share smoking as the most important common risk factor and there is a high prevalence of cardiovascular disease among COPD patients. Although cardioselective beta-blockers are safe in treatment of COPD, they are often withheld in these patients. In observational studies, beta-blocker treatment is associated with significantly reduced mortality and reduced risk of exacerbations of COPD. This effect may be caused by the beneficial effect of beta-blockers on heart failure, tachycardia and upregulation of beta-receptors in the airways.
AB - Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatmentChronic obstructive pulmonary disease (COPD) and coronary heart disease share smoking as the most important common risk factor and there is a high prevalence of cardiovascular disease among COPD patients. Although cardioselective beta-blockers are safe in treatment of COPD, they are often withheld in these patients. In observational studies, beta-blocker treatment is associated with significantly reduced mortality and reduced risk of exacerbations of COPD. This effect may be caused by the beneficial effect of beta-blockers on heart failure, tachycardia and upregulation of beta-receptors in the airways.
M3 - Tidsskriftartikel
C2 - 26376419
VL - 178
SP - 555
EP - 559
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 6
M1 - V02150184
ER -
ID: 153787727